… monitoring of these changes in patients and better monitoring of their reaction to treatment. …
progression and therapeutic response. Tracking a patient's response to therapy through short-…

… malignant transformation. 2HG represents an ideal biomarker to probe treatment response in
IDH-mutant glioma patients… resonance spectroscopy (MRS) as a result of antitumor therapy. …

… therapy is thought to be due largely to underlying tumor molecular and genomic heterogeneity,
which leads to differential treatment responses and patient … maintenance of glioma stem …

… At the time of the present study, the RANO criteria [7] had been updated with modified
radiological definitions for evaluation of tumor progression in malignant gliomas. This includes the …

… to more generally as the “parametric response map” (PRM), … of WHO grade 3 and 4 glioma
patients that was designed to … composite metrics of early treatment response as assessed 3 …

… glioma reporting data on the use of PET for guiding patient management. Our evidence
map … assessment of treatment response in patients with gliomas. Lancet Neurol 2010; 9:906–920 …

… new technique, called parametric response mapping (PRM), … assessment of therapeutic
response in patients with glioma [16… criteria for phase II studies of supratentorial malignant glioma…

… disease recurs in nearly all patients. While studies of novel imaging biomarkers have been
developed for early treatment response assessment, we sought … Malignant gliomas in adults …

… 28 patients affected by malignant brain tumours who underwent brain mapping-aided
surgical resection of neoplasm: 20 patients underwent awake surgical resection and 8 patients …

… Low values in ADC maps in solid gliomas are associated … for evaluating therapeutic response
in high-grade gliomas, uses … of gliomas is a treatment-related reaction of the tumor with an …